Colorectal cancer in young people shows genetic and structural differences that may make it more aggressive and ...

As colorectal cancer rates continue to rise among younger adults, a team of Boston researchers has identified differences in ...

For years, scientists have struggled to elucidate key biological differences between early onset colorectal cancer, typically ...

Diagnostic and surgical approaches to treating the disease are evolving — just as rates are spiking. Learn how the surgical ...

A new open-access review in Cancer Nanotechnology surveys how nanomaterials could improve colorectal cancer diagnosis, ...

Five colorectal cancer trials recently began treating patients, testing targeted drugs, bispecific antibodies and immunotherapy. Here’s what each one is studying. Clinical trials are how researchers ...

An AI tool that analyses tumour slides in minutes is helping doctors identify which colorectal cancer patients will benefit ...

INCY and GMAB team up to evaluate a three-drug combination for first-line treatment of KRAS G12D-mutated metastatic colorectal cancer.

New research in The Journal of Immunology uncovers how high blood sugar (hyperglycemia) and type 1 diabetes (T1D) may protect ...

Today we report on a troubling cancer trend among US adults of all ages. We also report on impressive survival data from a two-drug regimen ​that could be an alternative to more expensive ...

Randomized data support structured post-adjuvant exercise as a disease-modifying survivorship strategy, improving disease-free survival and overall survival compared with education-only control.

The landmark legislation marks a historic moment for states proactively aligning state policy with the latest research and innovations for colorectal cancer screening, improving access to lifesaving ...